Clinical Data, Safety and Statistical Centers (CDSSC)

Forecasted opportunity (not yet open for applications; expected to be posted around 2027-02-01; estimated application due date 2027-06-01). The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the support of the Clinical Data, Safety and Statistical Centers program. The overall objective of this program is to provide coordination and oversight for multiple activities in service to clinical research and mechanistic studies supported by NIAID, including all Division of Allergy, Immunology, and Transplantation’s Clinical Network activities. This program will provide a broad range of support critical for the design, development, implementation, and analysis of clinical research carried out by multiple division-supported programs in three disease areas: asthma and allergy, autoimmune diseases and transplantation. Support will include statistical design and analysis, protocol development, study initiation and management, data management, safety monitoring, sample tracking, final analysis of study findings, and manuscript development. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.